League
League is a health-tech company providing an AI-powered healthcare consumer experience platform to deliver personalized health and navigation solutions.
Secondary Market Price
How League Measures Up
To help you manage your League equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series C
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of League's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future League Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for League's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
League is a health-tech company that provides an AI-powered healthcare consumer experience platform. The company's platform is used by payers and providers to build and manage digital healthcare solutions, including benefits administration, member engagement, and care navigation. League currently powers the digital experiences for organizations such as CareSource, HCSC, SCAN, and Manulife, serving more than 63 million people globally. The company was founded in 2014 by Michael Serbinis, Daniel Leibu, and Dan Galperin. Headquartered in Toronto, with an office in Chicago, League has raised over $285 million in venture capital funding to date.
Looking forward, League plans to expand its global platform strategy with the goal of serving more than 100 million contracted users. The company is focused on helping healthcare organizations transition from transactional portals to more integrated digital platforms. Recent company developments support this growth phase, including the appointment of a new Chief Revenue Officer and Chief Delivery Officer. League has also been promoting 'League Connect,' an event for leaders in the healthcare industry, and its executives have been publicly discussing the role of AI in personalizing healthcare engagement.
- TDM Growth Partners
- Workday Ventures
- OMERS Ventures
- TELUS Ventures
- Wittington Ventures
- RBC Ventures
- Manulife Financial
- Real Ventures
- BDC IT Venture Fund
- Infinite Potential Technologies
- Co-Founder, Michael Serbinis
- Co-Founder, Dan Galperin
- Co-Founder, Dan Leibu
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is League worth joining?
Deciding if a startup like League is worth joining requires evaluating its growth potential against your personal financial goals. Tools like Prospect can help you assess a company's trajectory using data-driven models to inform your career decisions.
What should I do with my League stock?
Managing private company stock involves complex decisions about when to exercise options and how to plan for taxes. Platforms like Prospect can build a personalized strategy to help you optimize the value of your equity and minimize your tax burden.
Can you sell League stock?
Selling stock in a private company like League is usually only possible during company-approved liquidity events, such as tender offers, or on secondary markets. Prospect offers tools and guidance to help you navigate these opportunities and sell your shares at an optimal price.
How can I find the value of my League stock?
The value of stock in a private company isn't public and is often based on internal 409A valuations, which may not reflect its true market potential. Prospect uses predictive models trained on venture capital data to help you forecast what your equity could actually be worth.
What is League's equity worth?
A private company's equity valuation is not public information and fluctuates based on factors like funding rounds and overall business growth. To get a data-driven estimate, you can use platforms like Prospect, which analyze market signals to project a company's potential value.
What is League's stock ticker symbol?
Private, pre-IPO companies like League do not have a stock ticker symbol because their shares are not traded on public stock exchanges. Ticker symbols are only assigned when a company completes an Initial Public Offering (IPO).
Can I buy or sell League stock?
Buying stock in a private company is generally limited to employees exercising options or accredited investors, while selling is restricted to specific liquidity events. Tools from Prospect can help you navigate the complexities of exercising options and selling shares when the opportunity arises.
What is the criteria to buy or invest in League stock?
To invest in a private startup, you typically need to be an employee exercising stock options or an accredited investor with access to private funding rounds. Prospect is designed to help employees who already hold equity to manage and maximize its value, rather than facilitating new investments.
